SEMLER SCIENTIFIC, INC. Financials Semler Scientific, Inc.
Equities
SMLR
US81684M1045
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.33 USD | +1.00% |
|
+25.77% | -33.78% |
| May. 29 | Top Premarket Gainers | MT |
| May. 28 | Sector Update: Tech Stocks Advance Late Afternoon | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 313.5 | 629.4 | 619.3 | 225.7 | 297.9 | 207.2 |
| Enterprise Value (EV) 1 | 313.5 | 629.4 | 582 | 225.7 | 297.9 | 207.2 |
| P/E ratio | 25.5 x | 54 x | 43.2 x | 18.4 x | 16.8 x | 15 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 9.57 x | 16.3 x | 11.7 x | 3.98 x | 4.37 x | 3.75 x |
| EV / Revenue | 9.57 x | 16.3 x | 11.7 x | 3.98 x | 4.37 x | 3.75 x |
| EV / EBITDA | 26.8 x | 37.5 x | 30.9 x | 12.7 x | 13 x | 11.3 x |
| EV / FCF | - | 43,843,339 x | 39,353,406 x | - | - | - |
| FCF Yield | - | 0% | 0% | - | - | - |
| Price to Book | - | 25.5 x | 16.4 x | - | - | - |
| Nbr of stocks (in thousands) | 6,531 | 6,696 | 6,758 | 6,840 | 6,727 | 7,066 |
| Reference price 2 | 48.00 | 94.00 | 91.65 | 33.00 | 44.29 | 29.33 |
| Announcement Date | 3/3/20 | 3/1/21 | 2/28/22 | 3/21/23 | 3/5/24 | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Net sales 1 | 32.77 | 38.6 | 53.03 | 56.69 | 68.18 | 55.2 |
| EBITDA 1 | 11.7 | 16.79 | 20.07 | 17.79 | 22.86 | 18.4 |
| EBIT 1 | 10.71 | 15.96 | 19.44 | 17.2 | 22.26 | 17.6 |
| Operating Margin | 32.68% | 41.35% | 36.67% | 30.35% | 32.64% | 31.88% |
| Earnings before Tax (EBT) 1 | 10.7 | 16.49 | 19.46 | 17.69 | 24.1 | 20 |
| Net income 1 | 15.08 | 14.01 | 17.22 | 14.32 | 20.58 | 15.4 |
| Net margin | 46.03% | 36.28% | 32.48% | 25.27% | 30.19% | 27.9% |
| EPS 2 | 1.880 | 1.740 | 2.120 | 1.790 | 2.630 | 1.960 |
| Free Cash Flow | - | 14.36 | 15.74 | - | - | - |
| FCF margin | - | 37.19% | 29.68% | - | - | - |
| FCF Conversion (EBITDA) | - | 85.5% | 78.4% | - | - | - |
| FCF Conversion (Net income) | - | 102.49% | 91.38% | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/3/20 | 3/1/21 | 2/28/22 | 3/21/23 | 3/5/24 | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 11.54 | 14.02 | 14.83 | 14.05 | 13.79 | 18.21 | 18.6 | 16.32 | 15.06 | 15.9 | 14.2 | 13.1 | 12 |
| EBITDA 1 | 1.868 | 4.097 | 5.332 | 4.62 | 3.743 | 6.385 | 7.33 | 6.459 | 2.682 | 7.152 | 5.2 | 3.9 | 2.2 |
| EBIT 1 | 1.71 | 3.942 | 5.178 | 4.467 | 3.616 | 6.256 | 7.18 | 6.299 | 2.522 | 6.976 | 5 | 3.6 | 2 |
| Operating Margin | 14.82% | 28.12% | 34.92% | 31.8% | 26.21% | 34.36% | 38.59% | 38.61% | 16.75% | 43.87% | 35.21% | 27.48% | 16.67% |
| Earnings before Tax (EBT) 1 | 1.706 | 3.943 | 5.191 | 4.601 | 3.956 | 6.633 | 7.666 | 6.988 | 2.814 | 7.797 | 5.7 | 4.2 | 2.4 |
| Net income 1 | 1.507 | 3.36 | 4.074 | 3.675 | 3.216 | 4.969 | 5.879 | 5.514 | 4.221 | 6.073 | 4.4 | 3.2 | 1.8 |
| Net margin | 13.06% | 23.97% | 27.48% | 26.16% | 23.31% | 27.29% | 31.6% | 33.8% | 28.04% | 38.19% | 30.99% | 24.43% | 15% |
| EPS 2 | 0.1800 | 0.4100 | 0.5100 | 0.4600 | 0.4100 | 0.6300 | 0.7500 | 0.7100 | 0.5500 | 0.7800 | 0.5600 | 0.4100 | 0.2300 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/28/22 | 5/2/22 | 8/2/22 | 11/1/22 | 3/21/23 | 5/10/23 | 8/10/23 | 11/9/23 | 3/5/24 | 5/7/24 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | - | - | 37.3 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow | - | 14.4 | 15.7 | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share | - | 3.690 | 5.600 | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex | - | 1.06 | 0.32 | - | - | - |
| Capex / Sales | - | 2.75% | 0.6% | - | - | - |
| Announcement Date | 3/3/20 | 3/1/21 | 2/28/22 | 3/21/23 | 3/5/24 | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
29.33
USD
Average target price
40
USD
Spread / Average Target
+36.38%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -33.78% | 207M | |
| +75.69% | 12.57B | |
| -24.68% | 7.34B | |
| +6.22% | 6.61B | |
| +12.58% | 5.39B | |
| +26.90% | 4.53B | |
| -21.14% | 3.91B | |
| -22.99% | 2.91B | |
| +47.42% | 2.37B | |
| -0.37% | 2B |
- Stock Market
- Equities
- SMLR Stock
- Financials Semler Scientific, Inc.
